The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of anti-tumor adaptive immunity with clinical response in a phase II “Window” trial of neoadjuvant cetuximab in patients with resectable stage III-IV head and neck squamous carcinoma (HNSCC).
 
Robert L. Ferris
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Merck; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; VentiRx
 
Seungwon Kim
No Relationships to Disclose
 
Sumita Trivedi
No Relationships to Disclose
 
Raghvendra Mohan Srivastava
No Relationships to Disclose
 
Fernando Concha-Benavente
No Relationships to Disclose
 
Dwight Earl Heron
No Relationships to Disclose
 
David Andrew Clump
No Relationships to Disclose
 
Umamaheswar Duvvuri
Expert Testimony - Kolltan Pharmaceuticals
 
William E. Gooding
No Relationships to Disclose
 
Jonas Talmadge Johnson
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Merck Serono
Research Funding - AVEO; Bristol-Myers Squibb; Genentech; Lilly; VentiRx